{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n In abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", a prognostic signature composed of nine long noncoding RNAs (lncRNAs) was developed to predict overall survival in colorectal cancer patients. Although the study did not detail the individual mechanistic role of each lncRNA, LINC01571 is included as one of the components of this signature. Its expression level contributes to the stratification of patients into different mortality risk groups, suggesting that LINC01571 functions as a prognostic biomarker. In this context, dysregulation of LINC01571 appears to be associated with adverse patient outcomes, and incorporating its measurement into a multi‐lncRNA panel may improve individualized treatment decision making by more accurately reflecting the underlying tumor biology in colorectal cancer.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Zhiqiao Zhang, Qingbo Liu, Peng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PeerJ (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7717/peerj.6061"}], "href": "https://doi.org/10.7717/peerj.6061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30564521"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30564521"}]}]}]}